{"id":"W2970731184","doi":"10.1016/j.clml.2019.08.004","title":"Comparison of Time to Next Treatment, Health Care Resource Utilization, and Costs in Patients with Chronic Lymphocytic Leukemia Initiated on Front-line Ibrutinib or Chemoimmunotherapy","year":2019,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"National Cancer Institute; Janssen Scientific Affairs; Sunesis; AbbVie; BeiGene; TG Therapeutics","keywords":"Medicine; Chemoimmunotherapy; Ibrutinib; Hazard ratio; Internal medicine; Ofatumumab; Rituximab; Chronic lymphocytic leukemia; Oncology; Leukemia; Confidence interval; Lymphoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006541807,0.0007342208,0.002421891,0.000476293,0.0001366552,0.0000644777,0.0004304479,0.0005420293,0.0007242138],"category_scores_gemma":[0.0005263229,0.0005478735,0.000216432,0.0009810992,0.0004376209,0.0001762551,0.0001915718,0.0003407548,0.0006895802],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.1931544,"about_ca_system_score_gemma":0.07092841,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002064215,"about_ca_topic_score_gemma":0.0003976923,"domain_scores_codex":[0.9937351,0.0004657765,0.002234615,0.00138179,0.001055125,0.001127551],"domain_scores_gemma":[0.9951937,0.001379602,0.0006831893,0.001544813,0.0004229844,0.0007756703],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.04848307,0.0009900515,0.1479392,0.000616468,0.0004888662,0.00009779417,0.001956099,0.001259767,0.0001028091,0.00002296593,0.002634732,0.7954081],"study_design_scores_gemma":[0.1649767,0.03599229,0.7469093,0.002904619,0.0001231348,0.00004671994,0.0004455346,0.02638092,0.001471697,0.000002528534,0.01998554,0.0007610965],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9919075,0.001821569,0.00001199182,0.0001559002,0.0001134686,0.003654092,0.00007393191,0.0001464666,0.002115051],"genre_scores_gemma":[0.9945695,0.0003974174,0.0003421064,0.001612444,0.0001712557,0.00009324419,0.0007535816,0.0001763732,0.001884063],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.794647,"threshold_uncertainty_score":0.9996973,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07058158062732924,"score_gpt":0.3954478741314718,"score_spread":0.3248662935041426,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}